Sponsor

Lallemand Pharma Europe filial af Lallemand Pharma AG Schweiz

Denmark Bredstrupvej 33, 8500, Denmark

About the sponsor

Clinical research is centred on respiratory tract infections, with attention to reducing infection burden in children and supporting prevention during seasonal periods of higher risk.

Pediatric respiratory health
Infection prevention
Seasonal respiratory illness

The sponsor’s funded research reflects interest in upper and lower respiratory infection control within a paediatric population.

About Specializations

Lallemand Pharma Europe filial af Lallemand Pharma AG Schweiz runs clinical trials in conditions such as Respiratory tract infection, among others.

Respiratory tract infection

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Respiratory tract infection

Recruiting

A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

Registered drug

A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

Registered drug

Poland

Participants:0–17 years
Substances:Placebo
Sponsor:Lallemand Pharma Europe filial af Lallemand Pharma AG Schweiz

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →

About the sponsor

About Specializations

Ongoing trials

1 clinical trial

Respiratory tract infection

A study to evaluate the effectiveness of a drug combination in reducing respiratory tract infections in children aged 3 to 12 years.

Are you running a clinical trial?

Prefer not to search? Our Concierge searches the trials for you.